verified SJR 4,183 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · W.B. Saunders Ltd

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription Unclaimed

Cancer Treatment Reviews

Cancer Treatment Reviews is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 172. It has an SJR impact factor of 4,183 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,183.

Cancer Treatment Reviews focuses its scope in these topics and keywords: clinical, kinase, breast, malignant, strategies, decision, oncology, checkpoint, stabilization, replication, ...

ISSN: 0305-7372

Editorial: W.B. Saunders Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

4,183 Q1

H-index 172

Tasa de Aceptación pie_chart

22% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

4,183

H-index

172

Docs (year)

127

Docs 3y

286

Total refs

11947

Cites 3y

3171

Citable 3y

283

Cites/Doc 2y

11.01

Ref/Doc

94.07

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

The management of Hodgkin's disease

Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer

Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma

Pre-operative chemotherapy may improve survival for people with oesophageal cancer

Primary chemotherapy or hormonotherapy for patients with breast cancer

Prognostic and predictive factors in prostate cancer

Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues

Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease

The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning

Medulloblastoma in adults: clinical characteristics and treatment

The potential of melanoma antigen expression in cancer therapy

SHOW MORE ARTICLES

The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancer

The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy

The sentinel node negative axilla: Is it a no-go zone?

Thomas Hodgkin and the museum at Guy's Hospital

Thomas Hodgkin remembered

Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials

Twenty-five years of reviewing cancer treatment

Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis

Adjuvant interferon-alpha in malignant melanoma: current status

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer

Assessment of response to systemic therapy focusing on metastatic bone disease

Breast cancer risk following irradiation for Hodgkin's disease

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.